Total Payments
$227,685
2020 Payments
$50.22
Companies
11
Transactions
53
Medicare Patients
219
Medicare Billing
$20,227
Payment Breakdown by Category
Consulting$212,260 (93.2%)
Other$7,760 (3.4%)
Travel$3,201 (1.4%)
Research$3,194 (1.4%)
Food & Beverage$1,246 (0.5%)
Education$24.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $212,260 | 17 | 93.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,760 | 2 | 3.4% |
| Travel and Lodging | $3,201 | 7 | 1.4% |
| Unspecified | $3,194 | 3 | 1.4% |
| Food and Beverage | $1,246 | 20 | 0.5% |
| Education | $24.00 | 4 | 0.0% |
Payments by Type
General
$224,491
50 transactions
Research
$3,194
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim b.v. | $208,600 | 15 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $11,892 | 22 | $0 (2018) |
| Novartis Pharma AG | $3,194 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,060 | 1 | $0 (2017) |
| Relypsa, Inc. | $1,600 | 1 | $0 (2018) |
| Ethicon US, LLC | $137.60 | 2 | $0 (2017) |
| GENZYME CORPORATION | $79.71 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $50.22 | 2 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $33.25 | 1 | $0 (2019) |
| Veloxis Pharmaceuticals, Inc. | $24.00 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $50.22 | 2 | AstraZeneca Pharmaceuticals LP ($50.22) |
| 2019 | $2,198 | 4 | Novartis Pharma AG ($2,150) |
| 2018 | $62,995 | 13 | Boehringer Ingelheim b.v. ($55,120) |
| 2017 | $162,442 | 34 | Boehringer Ingelheim b.v. ($153,480) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $36.07 | General |
| 09/26/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.15 | General |
| 09/12/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 08/15/2019 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $14.89 | General |
| 03/30/2019 | Novartis Pharma AG | RAD001A_ZORTRESS_IMMUNOLOGY (Drug) | — | In-kind items and services | $1,106.00 | Research |
| Study: Publication support research related • Category: IMMUNOLOGY | ||||||
| 01/30/2019 | Novartis Pharma AG | ZORTRESS_ZORTRESS_IMMUNOLOGY (Drug) | — | In-kind items and services | $1,044.00 | Research |
| Study: Publication support research related • Category: IMMUNOLOGY | ||||||
| 11/23/2018 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Hyperkalemia | ||||||
| 07/17/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $91.12 | General |
| 05/23/2018 | Novartis Pharmaceuticals Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,880.00 | General |
| 05/23/2018 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $697.40 | General |
| 05/23/2018 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $247.81 | General |
| 05/23/2018 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $126.53 | General |
| 05/23/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.30 | General |
| 03/26/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | Consulting Fee | Cash or cash equivalent | $16,340.00 | General |
| Category: DIABETES | ||||||
| 02/26/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | Consulting Fee | Cash or cash equivalent | $25,780.00 | General |
| Category: DIABETES | ||||||
| 02/08/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $69.47 | General |
| Category: IMMUNOLOGY | ||||||
| 01/31/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $103.02 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2018 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | Consulting Fee | Cash or cash equivalent | $13,000.00 | General |
| Category: DIABETES | ||||||
| 01/03/2018 | Novartis Pharma AG | ZORTRESS (Drug) | — | In-kind items and services | $1,044.00 | Research |
| Study: Publication support research related • Category: IMMUNOLOGY | ||||||
| 12/26/2017 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | Consulting Fee | Cash or cash equivalent | $24,500.00 | General |
| Category: DIABETES | ||||||
| 11/26/2017 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | Consulting Fee | Cash or cash equivalent | $32,320.00 | General |
| Category: DIABETES | ||||||
| 11/02/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $92.06 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2017 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | Consulting Fee | Cash or cash equivalent | $17,220.00 | General |
| Category: DIABETES | ||||||
| 10/10/2017 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $79.71 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2017 | Boehringer Ingelheim b.v. | TRADJENTA (Drug) | Consulting Fee | Cash or cash equivalent | $9,400.00 | General |
| Category: DIABETES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Publication support research related | Novartis Pharma AG | $3,194 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 8 | 219 | 303 | $53,987 | $20,227 |
Total Patients
219
Total Services
303
Medicare Billing
$20,227
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 41 | 59 | $14,042 | $5,232 | 37.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 54 | 84 | $13,272 | $5,112 | 38.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 38 | $6,270 | $2,120 | 33.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 41 | 53 | $5,300 | $2,118 | 40.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 12 | $4,728 | $1,927 | 40.8% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 18 | 28 | $5,096 | $1,634 | 32.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 13 | $3,679 | $1,428 | 38.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 15 | 16 | $1,600 | $655.84 | 41.0% |
About Dr. Titte Srinivas, MD
Dr. Titte Srinivas, MD is a Nephrology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336189836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Titte Srinivas, MD has received a total of $227,685 in payments from pharmaceutical and medical device companies, with $50.22 received in 2020. These payments were reported across 53 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($212,260).
As a Medicare-enrolled provider, Srinivas has provided services to 219 Medicare beneficiaries, totaling 303 services with total Medicare billing of $20,227. Data is available for 1 year (2020–2020), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Cleveland, OH
- Active Since 06/07/2006
- Last Updated 12/18/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1336189836
Products in Payments
- TRADJENTA (Drug) $210,660
- ZORTRESS (Drug) $2,047
- Veltassa (Drug) $1,600
- RAD001A_ZORTRESS_IMMUNOLOGY (Drug) $1,106
- ZORTRESS_ZORTRESS_IMMUNOLOGY (Drug) $1,044
- ILARIS (Biological) $730.00
- ECHELON ENDOPATH Stapler (Device) $137.60
- THYMOGLOBULIN (Drug) $79.71
- ACTHAR (Biological) $33.25
- Envarsus XR (Drug) $24.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Cleveland
Sankar Navaneethan, Md, MD
Nephrology — Payments: $451,051
Nephrology $451,051
Dr. Georges Nakhoul, M.d, M.D
Nephrology — Payments: $159,362
Nephrology $159,362
Sevag Demirjian, Md, MD
Nephrology — Payments: $151,400
Nephrology $151,400
Amitkumar Patel, M.d, M.D
Nephrology — Payments: $68,997
Nephrology $68,997
Dr. James Simon, M.d, M.D
Nephrology — Payments: $63,895
Nephrology $63,895
Emilio Poggio, Md, MD
Nephrology — Payments: $47,784
Nephrology $47,784